ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 183 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 6.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $31,000 | -55.1% | 33,342 | -1.3% | 0.00% | – |
| Q4 2019 | $69,000 | -28.9% | 33,782 | 0.0% | 0.00% | – |
| Q3 2019 | $97,000 | -62.5% | 33,782 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $259,000 | -42.3% | 33,782 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $449,000 | -15.1% | 33,782 | -0.4% | 0.00% | -50.0% |
| Q4 2018 | $529,000 | -72.4% | 33,932 | -65.2% | 0.00% | -60.0% |
| Q3 2018 | $1,915,000 | +96.6% | 97,476 | +187.3% | 0.01% | +66.7% |
| Q2 2018 | $974,000 | +22.1% | 33,932 | +0.5% | 0.00% | +50.0% |
| Q1 2018 | $798,000 | +10.2% | 33,762 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $724,000 | -9.3% | 33,762 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $798,000 | +20.0% | 33,762 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $665,000 | -6.2% | 33,762 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $709,000 | +1.9% | 33,762 | -8.8% | 0.00% | 0.0% |
| Q4 2016 | $696,000 | -10.0% | 37,022 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $773,000 | -18.5% | 37,022 | -0.4% | 0.00% | -33.3% |
| Q2 2016 | $948,000 | -37.1% | 37,182 | -34.8% | 0.00% | -50.0% |
| Q1 2016 | $1,508,000 | -42.6% | 56,997 | -7.2% | 0.01% | -40.0% |
| Q4 2015 | $2,626,000 | +120.5% | 61,387 | +36.7% | 0.01% | +100.0% |
| Q3 2015 | $1,191,000 | -20.4% | 44,909 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $1,497,000 | +7.9% | 44,909 | +7.7% | 0.01% | 0.0% |
| Q1 2015 | $1,388,000 | -26.0% | 41,694 | -9.1% | 0.01% | -16.7% |
| Q4 2014 | $1,875,000 | +17.9% | 45,871 | -2.3% | 0.01% | +20.0% |
| Q3 2014 | $1,591,000 | -1.2% | 46,960 | -1.7% | 0.01% | 0.0% |
| Q2 2014 | $1,611,000 | -11.0% | 47,780 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $1,811,000 | +29.8% | 47,780 | 0.0% | 0.01% | +50.0% |
| Q4 2013 | $1,395,000 | -15.1% | 47,780 | -0.3% | 0.00% | -20.0% |
| Q3 2013 | $1,643,000 | -8.3% | 47,931 | -11.7% | 0.01% | -16.7% |
| Q2 2013 | $1,791,000 | – | 54,292 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |